XML 30 R8.htm IDEA: XBRL DOCUMENT v3.19.3
EARNINGS PER SHARE
9 Months Ended
Sep. 30, 2019
EARNINGS PER SHARE  
EARNINGS PER SHARE

NOTE 2 – EARNINGS PER SHARE

Basic earnings per common share is based only on the average number of shares of Common Stock outstanding for the periods.

Diluted earnings per common share reflects the effect of shares of Common Stock issuable upon the exercise of options, unless the effect on earnings is antidilutive. Diluted earnings per common share is computed using the treasury stock method. Under this method, the aggregate number of shares of Common Stock outstanding reflects the assumed use of proceeds from the hypothetical exercise of any outstanding options to purchase shares of Common Stock. The average market value for the period is used as the assumed purchase price.

The following table sets forth the elements of basic and diluted earnings per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Three months ended

    

Nine months ended

 

 

September 30, 

 

September 30, 

 

    

2019

    

2018

    

2019

    

2018

Numerator for basic and diluted earnings per common share:

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

136,000

 

$

541,000

 

$

5,798,000

 

$

911,000

 

 

 

 

 

 

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Denominator for basic earnings per share - weighted average common shares outstanding

 

 

3,144,000

 

 

3,701,000

 

 

3,229,000

 

 

3,626,000

Dilutive securities (1)

 

 

49,000

 

 

83,000

 

 

60,000

 

 

112,000

Denominator for diluted earnings per share - weighted average common shares outstanding

 

 

3,193,000

 

 

3,784,000

 

 

3,289,000

 

 

3,738,000


(1)Dilutive securities consist of “in the money” stock options.

 

At September 30, 2019 and 2018, there were outstanding stock options whose exercise prices were higher than the average market values of the underlying Common Stock for the period. The weighted average of anti-dilutive stock options outstanding was as follows:

 

 

 

 

 

 

 

 

 

 

 

    

Three months ended

    

Nine months ended

 

 

September 30, 

 

September 30, 

 

    

2019

    

2018

    

2019

    

2018

Weighted average antidilutive stock options outstanding

 

57,000

 

 —

 

24,000

 

16,000